Drug intelligence / Profile preview

Xuezhi Ling Pian

Development stage: Unknown
Lead developer: Zhejiang Tianyitang Pharmaceutical
Administration: Oral

Overview

Xuezhi Ling Pian is a traditional Chinese medicine (TCM) tablet developed and manufactured by Zhejiang Tianyitang Pharmaceutical. It is primarily indicated for the treatment of hyperlipidemia and the regulation of elevated blood lipid levels. The formulation is based on traditional Chinese medical principles aimed at invigorating the spleen, resolving phlegm, and promoting blood circulation to manage lipid metabolism. It typically consists of a combination of herbal ingredients, including *Polygonum multiflorum* (He Shou Wu), *Crataegus pinnatifida* (Shan Zha), and *Alisma plantago-aquatica* (Ze Xie). The product is commercially available and approved in China as a pharmaceutical TCM product for managing lipid disorders.

Brand names: Xuezhi Ling Pian
Other names: Blood Lipid PillsXuezhiling Tablets血脂灵片

Beyond the preview

Go deeper on Xuezhi Ling Pian.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xuezhi Ling Pian.

Explore the full profile